BioMidwest
Filter News
Found 67,415 articles
-
BioSpace Hotbed maps have been a life sciences industry staple for over 30 years. Today the program features eight regional Hotbed Maps and the NextGen Bio Map which highlights some of the industry’s most promising startups.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 18, 2020.
-
CHMP Recommends Approval of Lilly's Baricitinib for the Treatment of Adults with Moderate to Severe Atopic Dermatitis
9/18/2020
Eli Lilly and Company (NYSE:LLY) and Incyte (NASDAQ:INCY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for baricitinib for the treatment of adult patients with moderate to severe atopic dermatitis (AD) who are candidates for systemic therapy.
-
Spectrum Pharmaceuticals Presents Results in HER2 Exon 20 Insertion Mutations from Cohort 2 of the Poziotinib ZENITH20 Clinical Trial
9/18/2020
Spectrum Pharmaceuticals, a biopharmaceutical company focused on novel and targeted oncology therapies, presented additional results from its pivotal Phase 2 clinical trial, ZENITH20, evaluating poziotinib in previously treated non-small cell lung cancer patients with HER2 exon 20 insertion mutations.
-
Chicago Biotech Demonstrates Monoclonal Antibody Tolerability with No Adverse Effects
9/18/2020
SIWA Therapeutics, Inc., has announced positive results that support further development of its monoclonal antibody, 318H, as a broad-spectrum antiviral drug.
-
Medexus Engages Adelaide Capital for Investor Relations Services and Reports Annual Meeting Results
9/18/2020
Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) is pleased to announce that it has entered into a consulting agreement (the “ Consulting Agreement ”) with Adelaide Capital (“ Adelaide ”) to provide investor relations consulting services to the Company in compliance with the policies and guidelines of the TSX Venture Exchange (the “ TSXV ”) and applicable legislation. Adelaide will
-
Beech Tree Labs selects Curavit Clinical Research for fully virtual COVID-19 clinical trial
9/18/2020
Beechtree Labs has chosen Curavit Clinical Research for a fully decentralized clinical trial to investigate a promising Covid-19 therapy.
-
Exicure announced positive results from its Phase Ib trial evaluating cavrotolimod, its SNA-enabled TLR9 agonist, that is being developed for the treatment of solid tumors, in combination with pembrolizumab.
-
Mindleap Health Implements HIPAA Compliance Standards and Appoints Former Canadian Ministry of Health Telemedicine Expert as Head of Program Management
9/17/2020
Mydecine Innovations Group, Inc., is pleased to announce that its wholly-owned subsidiary, Mindleap Health, has implemented a comprehensive information security rollout of next-generation cyber-security solutions to meet HIPAA compliance standards.
-
QIAGEN fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR-based diagnostic automation systems
9/17/2020
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the acquisition of the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular, Inc. for $248 million in cash.
-
Deloitte Names Tina Wheeler National Sector Leader for Health Care
9/17/2020
Deloitte has appointed Tina Wheeler as national sector leader for the health care practice in the U.S. effective immediately. Wheeler, a partner with Deloitte & Touche
-
Riverside Radiology and Interventional Associates (RRIA), A LucidHealth Company, receives 'Exceptional' clinical care rating by the Louis Stokes Cleveland VAMC
9/17/2020
Riverside Radiology and Interventional Associates (RRIA), A LucidHealth Company, provides teleradiology physician services to veteran beneficiaries at the Louis Stokes Veterans Affairs Medical Center (VAMC) in Cleveland . The practice's board-certified radiologists have been providing diagnostic imaging interpretation and opera
-
FAST BioMedical Establishes World-Recognized Heart Failure Medical Advisory Board
9/17/2020
Steven Zelenkofske appointed chairman to provide expertise in heart failure clinical development. [17-September-2020] INDIANAPOLIS , Sept. 17, 2020 /PRNewswire/ -- FAST BioMedical , a late clinical-stage medical technology company, today announces establishing a Heart Failure Medical Advisory Board of world-recognized physicians, nurses and researchers. The Board w
-
Abbott Declares 387th Consecutive Quarterly Dividend
9/17/2020
The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 36 cents per share. This marks the 387 th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Nov. 16, 2020, to shareholders of record at the close of business on Oct. 15, 2020 . Abbott h
-
Valisure And Premier Rx Announce Partnership To Expand Distribution Of Certified Generic Drugs
9/17/2020
Premier Rx becomes the first national wholesale distributor of independently batch-certified generic medications [17-September-2020] NEW HAVEN, Conn. and WEST CHESTER, Ohio , Sept. 17, 2020 /PRNewswire/ -- Valisure, an online pharmacy attached to an analytical laboratory that chemically certifies every medication it sells, and Premier Rx, an independent pharmaceutic
-
Valent BioSciences Moves Into New Global Biorational Headquarters
9/17/2020
Valent BioSciences LLC officially moved its global Biorational Headquarters (BHQ) to Innovation Park in Libertyville, Ill. The new headquarters is situated in the same complex as the more than 90,000-square-foot Biorational Research Center (BRC), which relocated from Long Grove, Ill., in 20
-
U.S. Deputy Secretary of Energy Mark W. Menezes Visits NorthStar Medical Radioisotopes
9/17/2020
NorthStar Medical Radioisotopes, LLC, a global innovator in the production and distribution of radioisotopes used for medical imaging, today announced that Deputy Secretary of Energy Mark W. Menezes visited the Company’s Beloit, Wis. headquarters on September 11, 2020.
-
Jeff Winton Associates To Expand Global Healthcare Communications Services In Collaboration With UK-Based Onyx Health
9/17/2020
Jeff Winton Associates, a full-service communications agency for the pharmaceutical, biotechnology and other life sciences industries, today announced expansion into additional global markets through a new partnership with UK-based marketing communications firm Onyx Health.
-
BioSTL Launches Center for Defense Medicine with $1.5M Grant from Economic Development Administration
9/17/2020
BioSTL has won a $1.5 million grant from the Economic Development Administration (EDA) of the U.S. Department of Commerce to launch a new Center for Defense Medicine in St. Louis.
-
Bio-Techne and QIAGEN Announce Expansion and Extension of Exosome Partnership
9/17/2020
Bio-Techne Corporation and QIAGEN N.V. announced the expansion and extension of a non-exclusive partnership to co-market exosome technology to existing and potential biopharma partners as well as the joint development of new exosome based products.